Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 536.00
Bid: 538.00
Ask: 541.00
Change: -11.00 (-2.01%)
Spread: 3.00 (0.558%)
Open: 544.00
High: 544.00
Low: 535.00
Prev. Close: 547.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

14 Jan 2011 07:00

RNS Number : 4390Z
Polar Capital Holdings PLC
14 January 2011
 



14 January 2011

 

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Comment

 

We are pleased to report an increase of 40% in our AUM to over $3.5bn in the nine month period to December 2010. The Group remains confident that its strategy of growing its established funds to capacity and expanding its product range through both hiring and acquiring new teams will continue to drive future AUM growth.

 

We are also pleased to confirm an increase in net performance fee receipts over the period. Such fees total £5.6m (2009: £2.3m) as a result of the continued good performance of a number of the Group's products.

 

Group AUM (unaudited)

 

The table below sets out the Group's AUM as at 31 December 2010 and the movements experienced in the nine month period since 31 March 2010:

 

AUM movement

Nine months to 31 Dec 10

Long only funds

$m

Hedge funds

$m

Total

$m

As at 31 Mar 2010

$1,575m

$955m

$2,530m

Performance and currency movements

$259m

$18m

$277m

Acquisition of HIM Capital

$249m

-

$249m

Net subscriptions / (redemptions) from ongoing businesses

$572m

$(122)m

$450m

Total AUM at 31 Dec 10

$2,655m

$851m

$3,506m

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fees (after the deduction of staff interests) earned and accrued in the first nine months of the Group's financial year.

 

Performance fees

net of staff allocations

Nine months to

31 Dec 09

£m

Year to

31 Mar 10

(year end)

£m

Nine months to

31 Dec 10

£m

Received

£1.9m

£2.5m

£5.6m

Accrued but not yet earned in funds with year ends on or before the financial year end

£0.4m

n/a

£0.0m

Total net performance fees

£2.3m

£2.5m

£5.6m

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (CFO)

+44 (0)20 7227 2700

 

Numis Securities

Simon Blank (Nominated Adviser)

Charles Farquhar (Corporate Broking)

 

 

+44 (0)20 7260 1000

 

Financial Dynamics

Ed Gascoigne-Pees

Georgina Turner

 

 

+44 (0)20 7269 7132

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALFDFLPFEFF
Date   Source Headline
30th Jul 20205:23 pmRNSForm 8.3 - HASTINGS GROUP HOLDINGS PLC
29th Jul 20207:00 amRNSResult of AGM
22nd Jul 20204:15 pmRNSIssue of Equity
22nd Jul 202012:10 pmRNSDirector/PDMR Shareholding
10th Jul 20202:07 pmRNSDirector/PDMR Shareholding
10th Jul 20202:06 pmRNSDirector/PDMR Shareholding
9th Jul 20207:00 amRNSAuM Update
7th Jul 20208:03 amRNSHolding(s) in Company
6th Jul 202010:08 amRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSForm 8.3 - Cello Health PLC
2nd Jul 20209:19 amRNSDirector/PDMR Shareholding
1st Jul 20202:10 pmRNSIssue of Equity
1st Jul 20207:00 amRNSTotal Voting Rights
29th Jun 202010:03 amRNSDirector/PDMR Shareholding
26th Jun 20201:10 pmRNSAnnual Financial Report
25th Jun 202010:26 amRNSHolding(s) in Company
25th Jun 202010:25 amRNSDirector/PDMR Shareholding
24th Jun 20203:29 pmRNSIssue of Equity
22nd Jun 20204:04 pmRNSDividend Declaration
22nd Jun 20207:00 amRNSGroup Audited Results for year ended 31 March 2020
18th Jun 202012:08 pmRNSSecond Price Monitoring Extn
18th Jun 202012:02 pmRNSPrice Monitoring Extension
5th Jun 202010:31 amRNSDirector/PDMR Shareholding
4th Jun 20207:16 amRNSNotice of Results
1st Jun 20207:00 amRNSTotal Voting Rights
19th May 20202:00 pmRNSIssue of Equity
12th May 202010:22 amRNSDirector/PDMR Shareholding
11th May 20201:15 pmRNSDirectorate Change
6th May 202011:36 amRNSHolding(s) in Company
4th May 20201:07 pmRNSIssue of Equity
4th May 202011:24 amRNSDirector/PDMR Shareholding
15th Apr 202012:00 pmRNSFund Termination
9th Apr 20204:26 pmRNSDirectorate Change
9th Apr 202012:02 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSAuM Update
7th Apr 20204:40 pmRNSSecond Price Monitoring Extn
7th Apr 20204:35 pmRNSPrice Monitoring Extension
7th Apr 20207:00 amRNSBoard Changes
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202012:08 pmRNSSecond Price Monitoring Extn
30th Mar 202012:02 pmRNSPrice Monitoring Extension
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
19th Mar 202012:07 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.